StonvexLoading…
StonvexStonvexStonvexCore line items from ZM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $4.87B | $4.67B | $4.53B | $4.39B |
Operating Income | $1.12B | $813.29M | $525.28M | $245.43M |
Net Income | $1.90B | $1.01B | $637.46M | $103.71M |
EPS (Diluted) | $6.18 | $3.21 | $2.07 | $0.34 |
Total Assets | $11.96B | $10.99B | $9.93B | $8.13B |
Total Liabilities | $2.15B | $2.05B | $1.91B | $1.92B |
Cash & Equivalents | $1.27B | $1.35B | $1.56B | $1.09B |
Free Cash Flow OCF − CapEx | $1.92B | $1.81B | $1.47B | $1.19B |
Shares Outstanding | 307.33M | 315.07M | 308.52M | 304.23M |